The impact of GIK solution injection on recovery in patients with coronary stenosis

Determining the effect of intracoronary administration of glucose-insulin-potassium (GIK) solution during primary percutaneous intervention on reperfusion injury

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250923067334N1

Enrollment

Registered

2025-12-12

Start date

2025-11-22

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Innfarction. Thrombosis of atrium, auricular appendage, and ventricle as current complications following acute myocardial infarction

Interventions

Intervention 1: Intervention group: Glucose-insulin-potassium (GIK) solution is used for the treatment of acute myocardial infarction as a polarizing agent to promote electrical stability and also as

Eligibility

Sex/Gender

All

Age

40 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients who are subjected to primary percutaneous coronary intervention (PCI) Informed consent for participation

Exclusion criteria

Exclusion criteria: Patients with inflammatory disorders Impairment in other organs Cardiovascular diseases rather than coronary artery disease

Design outcomes

Primary

Measure	Time frame
TIMI flow index. Timepoint: Every 6 hours. Method of measurement: Angiography.;Reperfusion arrhythmia. Timepoint: Every 6 hours. Method of measurement: Electrocardiogram.;Troponin level. Timepoint: Every 6 hours. Method of measurement: Specific kit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactIman Razeghian-Jahromi

Shiraz University of Medical Sciences

razejahromi@yaho.com+98 71 3612 2235

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026